EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic Rat

Rodrigo V Placido, Rafaela F Rodrigues, Lellis H Costa, Taila Kawano, Milton K Aquino, Gabriella B Martinez, Mariana T R Hummel, Maria Eduarda T de Lima, Rui M P da Silva, Norberto Garcia-Cairasco iD, Silvia G Ruginsk iD, Marília G A G Pereira iD und 1 weitere

International Journal of Molecular Sciences · 16.04.2026 · 27 (8) · 3544

DOI: 10.3390/ijms27083544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2026. Verfasst von Rodrigo V Placido und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Faculty, Federal University of Alfenas, Alfenas 37130-001, MG, Brazil. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1, Epilepsy, Epilepsy, Reflex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Minas Gerais State Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance remains a major challenge in epilepsy, and overexpression of ATP-binding cassette transporters, particularly P-glycoprotein (P-gp), at the blood–brain barrier (BBB) has been consistently implicated in limiting central nervous system drug exposure. Genetic experimental models suitable for investigating molecular regulation and functional alterations of P-gp in epilepsy remain scarce. This study evaluated P-gp expression and functional alterations in the Wistar Audiogenic Rat (WAR), a genetic model of epilepsy exhibiting phenotypic heterogeneity. WAR animals were classified into refractory epilepsy (WAR-RE) or temporal lobe epilepsy (WAR-TLE) phenotypes and compared with non-epileptic Wistar controls. Fexofenadine, a well-established in vivo P-gp probe substrate, was administered orally, and plasma pharmacokinetic parameters were determined. P-gp expression at the BBB was assessed by immunohistochemistry in hippocampal regions. WAR-RE animals exhibited significantly increased systemic exposure to fexofenadine, characterized by higher area under the curve and prolonged half-life, alongside reduced apparent clearance, compared with control animals (p < 0.05). In contrast, WAR-TLE animals showed greater interindividual variability without statistically significant differences. Immunohistochemical analysis revealed increased P-gp expression in hippocampal microvessels in both WAR phenotypes. These findings demonstrate that the WAR model displays molecular upregulation of P-gp at the BBB, accompanied by functional alterations in the disposition of a prototypical P-gp substrate. Although direct brain drug concentrations were not assessed, the integration of systemic pharmacokinetics with transporter expression supports the use of WAR as a genetic proof-of-concept model for studying P-gp regulation and transporter-mediated drug disposition in epilepsy. This model provides a valuable molecular framework for future investigations addressing transporter modulation and mechanisms underlying pharmacoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 1EpilepsyEpilepsy, ReflexAnimalsRats, WistarRatsDisease Models, AnimalBlood-Brain BarrierMaleTerfenadineHippocampus

Stichwörter der Autor:innen

ATP binding cassette transporterdrug resistancedrug resistant epilepsyepilepsymember 1pharmacokineticssubfamily B

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1Terfenadinefexofenadine

Autor:innen und Institutionen

  • Pharmaceutical Sciences Faculty, Federal University of Alfenas, Alfenas 37130-001, MG, Brazil.
  • Neurophysiology and Experimental Neuroethology Laboratory, Department of Physiology, University of São Paulo, Ribeirão Preto 05508-220, SP, Brazil.
  • Institute of Biomedical Sciences, Federal University of Alfenas, Alfenas 37130-001, MG, Brazil.

ORCID-Profile: Norberto Garcia-Cairasco, Silvia G Ruginsk, Marília G A G Pereira, Vanessa B Boralli

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Minas Gerais State Research Foundation

Zitieren

APA

Placido, R. V., Rodrigues, R. F., Costa, L. H., Kawano, T., Aquino, M. K., Martinez, G. B., Hummel, M. T. R., de Lima, M. E. T., da Silva, R. M. P., Garcia-Cairasco, N., Ruginsk, S. G., Pereira, M. G. A. G., & Boralli, V. B. (2026). Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic Rat. International Journal of Molecular Sciences, 27(8), 3544. https://doi.org/10.3390/ijms27083544

Vancouver

Placido RV, Rodrigues RF, Costa LH, Kawano T, Aquino MK, Martinez GB, et al. Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic Rat. International Journal of Molecular Sciences. 2026;27(8):3544. doi:10.3390/ijms27083544

BibTeX
@article{Placido2026,
  author = {Placido, Rodrigo V and Rodrigues, Rafaela F and Costa, Lellis H and Kawano, Taila and Aquino, Milton K and Martinez, Gabriella B and Hummel, Mariana T R and de Lima, Maria Eduarda T and da Silva, Rui M P and Garcia-Cairasco, Norberto and Ruginsk, Silvia G and Pereira, Marília G A G and Boralli, Vanessa B},
  title = {Molecular and Functional Alterations of P-Glycoprotein in a Genetic Model of Epilepsy: Insights from the Wistar Audiogenic Rat},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3544},
  doi = {10.3390/ijms27083544}
}
Kostenlos starten →